NCT05683418 2026-04-22A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast CancerTotus MedicinesPhase 1 Recruiting241 enrolled
NCT06993844 2026-03-17Phase 1/2 Study of ETX-636 in Participants With Advanced Solid TumorsEnsem TherapeuticsPhase 1/2 Recruiting233 enrolled